Cargando…
The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer
Inflammation has been reported to play an important role in cancer progression and various inflammatory markers have been reported to be useful prognostic markers. The aim of this retrospective study was to evaluate the significance of the C-reactive protein to albumin (CRP/ALB) ratio in colorectal...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069226/ https://www.ncbi.nlm.nih.gov/pubmed/27812440 http://dx.doi.org/10.1186/s40064-016-3529-y |
_version_ | 1782460897297432576 |
---|---|
author | Shibutani, Masatsune Maeda, Kiyoshi Nagahara, Hisashi Iseki, Yasuhito Hirakawa, Kosei Ohira, Masaichi |
author_facet | Shibutani, Masatsune Maeda, Kiyoshi Nagahara, Hisashi Iseki, Yasuhito Hirakawa, Kosei Ohira, Masaichi |
author_sort | Shibutani, Masatsune |
collection | PubMed |
description | Inflammation has been reported to play an important role in cancer progression and various inflammatory markers have been reported to be useful prognostic markers. The aim of this retrospective study was to evaluate the significance of the C-reactive protein to albumin (CRP/ALB) ratio in colorectal cancer patients who received palliative chemotherapy. We performed a retrospective review of 99 patients who underwent palliative chemotherapy for unresectable colorectal cancer between 2005 and 2010. The cutoff value of the CRP/ALB ratio was determined based on a receiver operating characteristics curve analysis. The relationship between the CRP/ALB ratio and survival was assessed. The cutoff value for the CRP/ALB ratio was 0.183. The high pretreatment CRP/ALB ratio group showed significantly worse overall survival. Patients with a high pretreatment CRP/ALB ratio and in whom the CRP/ALB ratio normalized after chemotherapy tended to have better overall survival than those in whom both the pretreatment and posttreatment CRP/ALB ratios were high. The CRP/ALB ratio is a useful marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer. |
format | Online Article Text |
id | pubmed-5069226 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-50692262016-11-03 The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer Shibutani, Masatsune Maeda, Kiyoshi Nagahara, Hisashi Iseki, Yasuhito Hirakawa, Kosei Ohira, Masaichi Springerplus Research Inflammation has been reported to play an important role in cancer progression and various inflammatory markers have been reported to be useful prognostic markers. The aim of this retrospective study was to evaluate the significance of the C-reactive protein to albumin (CRP/ALB) ratio in colorectal cancer patients who received palliative chemotherapy. We performed a retrospective review of 99 patients who underwent palliative chemotherapy for unresectable colorectal cancer between 2005 and 2010. The cutoff value of the CRP/ALB ratio was determined based on a receiver operating characteristics curve analysis. The relationship between the CRP/ALB ratio and survival was assessed. The cutoff value for the CRP/ALB ratio was 0.183. The high pretreatment CRP/ALB ratio group showed significantly worse overall survival. Patients with a high pretreatment CRP/ALB ratio and in whom the CRP/ALB ratio normalized after chemotherapy tended to have better overall survival than those in whom both the pretreatment and posttreatment CRP/ALB ratios were high. The CRP/ALB ratio is a useful marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer. Springer International Publishing 2016-10-18 /pmc/articles/PMC5069226/ /pubmed/27812440 http://dx.doi.org/10.1186/s40064-016-3529-y Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Research Shibutani, Masatsune Maeda, Kiyoshi Nagahara, Hisashi Iseki, Yasuhito Hirakawa, Kosei Ohira, Masaichi The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer |
title | The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer |
title_full | The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer |
title_fullStr | The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer |
title_full_unstemmed | The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer |
title_short | The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer |
title_sort | significance of the c-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069226/ https://www.ncbi.nlm.nih.gov/pubmed/27812440 http://dx.doi.org/10.1186/s40064-016-3529-y |
work_keys_str_mv | AT shibutanimasatsune thesignificanceofthecreactiveproteintoalbuminratioasamarkerforpredictingsurvivalandmonitoringchemotherapeuticeffectivenessinpatientswithunresectablemetastaticcolorectalcancer AT maedakiyoshi thesignificanceofthecreactiveproteintoalbuminratioasamarkerforpredictingsurvivalandmonitoringchemotherapeuticeffectivenessinpatientswithunresectablemetastaticcolorectalcancer AT nagaharahisashi thesignificanceofthecreactiveproteintoalbuminratioasamarkerforpredictingsurvivalandmonitoringchemotherapeuticeffectivenessinpatientswithunresectablemetastaticcolorectalcancer AT isekiyasuhito thesignificanceofthecreactiveproteintoalbuminratioasamarkerforpredictingsurvivalandmonitoringchemotherapeuticeffectivenessinpatientswithunresectablemetastaticcolorectalcancer AT hirakawakosei thesignificanceofthecreactiveproteintoalbuminratioasamarkerforpredictingsurvivalandmonitoringchemotherapeuticeffectivenessinpatientswithunresectablemetastaticcolorectalcancer AT ohiramasaichi thesignificanceofthecreactiveproteintoalbuminratioasamarkerforpredictingsurvivalandmonitoringchemotherapeuticeffectivenessinpatientswithunresectablemetastaticcolorectalcancer AT shibutanimasatsune significanceofthecreactiveproteintoalbuminratioasamarkerforpredictingsurvivalandmonitoringchemotherapeuticeffectivenessinpatientswithunresectablemetastaticcolorectalcancer AT maedakiyoshi significanceofthecreactiveproteintoalbuminratioasamarkerforpredictingsurvivalandmonitoringchemotherapeuticeffectivenessinpatientswithunresectablemetastaticcolorectalcancer AT nagaharahisashi significanceofthecreactiveproteintoalbuminratioasamarkerforpredictingsurvivalandmonitoringchemotherapeuticeffectivenessinpatientswithunresectablemetastaticcolorectalcancer AT isekiyasuhito significanceofthecreactiveproteintoalbuminratioasamarkerforpredictingsurvivalandmonitoringchemotherapeuticeffectivenessinpatientswithunresectablemetastaticcolorectalcancer AT hirakawakosei significanceofthecreactiveproteintoalbuminratioasamarkerforpredictingsurvivalandmonitoringchemotherapeuticeffectivenessinpatientswithunresectablemetastaticcolorectalcancer AT ohiramasaichi significanceofthecreactiveproteintoalbuminratioasamarkerforpredictingsurvivalandmonitoringchemotherapeuticeffectivenessinpatientswithunresectablemetastaticcolorectalcancer |